Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT03759678Phase 2Terminated
- Sponsor
- IntraBio
- Start
- Jan 2020
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of levacetylleucine in ataxia-telangiectasia (AT), sponsored by IntraBio. Started Jan 2020; status: terminated.
02
Drugs
levacetylleucine
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on NCT03759678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03759678.